Guselkumab for treating chronic plaque psoriasis in children aged 6 to 17 years TSID 12002Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Secukinumab biosimilar for treating plaque psoriasis TSID 11992Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Spesolimab for preventing generalised pustular psoriasis flares [ID6216]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC